Elizabeth A. Belloli

Elizabeth A. Belloli

Pulmonary Medicine | Intensive Care Medicine
1500 E Medical Center Dr
Floor 3 Reception C
Ann Arbor, MI 48109

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications

Crushed Posaconazole Delayed-Release Tablets Have Reduced Bioavailability and Interaction With Tacrolimus Relative to Other Administration Routes.

Crushed Posaconazole Delayed-Release Tablets Have Reduced Bioavailability and Interaction With Tacrolimus Relative to Other Administration Routes.

Journal: The Annals of pharmacotherapy
Published: May 05, 2026

Survival According to Radiomic and Visual UIP Classification in Fibrotic ILD.

Survival According to Radiomic and Visual UIP Classification in Fibrotic ILD.

Journal: Chest
Published: April 14, 2026

A Quantitative Imaging Measure of Progressive Pulmonary Fibrosis.

A Quantitative Imaging Measure of Progressive Pulmonary Fibrosis.

Journal: American journal of respiratory and critical care medicine
Published: July 18, 2025

Performance Characteristics for Physiological Measures of Progressive Pulmonary Fibrosis.

Performance Characteristics for Physiological Measures of Progressive Pulmonary Fibrosis.

Journal: American journal of respiratory and critical care medicine
Published: June 18, 2025

Assessment of Antimetabolite Intolerance in Older Lung Transplant Recipients.

Assessment of Antimetabolite Intolerance in Older Lung Transplant Recipients.

Journal: Progress in transplantation (Aliso Viejo, Calif.)
Published: April 14, 2025

Safety and Tolerability of SGLT-2 Inhibitors Following Lung Transplantation.

Safety and Tolerability of SGLT-2 Inhibitors Following Lung Transplantation.

Journal: Clinical transplantation
Published: July 10, 2024

Impact of tacrolimus vs cyclosporine on chronic lung allograft dysfunction incidence and allograft survival in the International Society of Heart and Lung Transplantation registry.

Impact of tacrolimus vs cyclosporine on chronic lung allograft dysfunction incidence and allograft survival in the International Society of Heart and Lung Transplantation registry.

Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Published: May 28, 2024

Pamrevlumab for Idiopathic Pulmonary Fibrosis: The ZEPHYRUS-1 Randomized Clinical Trial.

Pamrevlumab for Idiopathic Pulmonary Fibrosis: The ZEPHYRUS-1 Randomized Clinical Trial.

Journal: JAMA
Published: May 19, 2024

Acute exacerbations in patients with progressive pulmonary fibrosis.

Acute exacerbations in patients with progressive pulmonary fibrosis.

Journal: ERJ open research
Published: April 18, 2024

Results from randomized trial of pirfenidone in patients with chronic rejection (STOP-CLAD study).

Results from randomized trial of pirfenidone in patients with chronic rejection (STOP-CLAD study).

Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Published: January 11, 2024

Systemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive disease.

Systemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive disease.

Journal: Rheumatology (Oxford, England)
Published: April 17, 2022

Radiographic Graft Surveillance in Lung Transplantation: Prognostic Role of Parametric Response Mapping.

Radiographic Graft Surveillance in Lung Transplantation: Prognostic Role of Parametric Response Mapping.

Journal: American journal of respiratory and critical care medicine
Published: July 28, 2021
Showing 1-12 of 28

Last Updated: 09/26/2026